Exhaled breath analysis allows exclusive screening for malignant pleural mesothelioma

Author(s):  
Kevin Lamote ◽  
Matthijs Vynck ◽  
Olivier Thas ◽  
Joris Van Cleemput ◽  
Kristiaan Nackaerts ◽  
...  
Author(s):  
Zehra Nur Töreyin ◽  
Manosij Ghosh ◽  
Özlem Göksel ◽  
Tuncay Göksel ◽  
Lode Godderis

Malignant pleural mesothelioma (MPM) is mainly related to previous asbestos exposure. There is still dearth of information on non-invasive biomarkers to detect MPM at early stages. Human studies on exhaled breath biomarkers of cancer and asbestos-related diseases show encouraging results. The aim of this systematic review was to provide an overview on the current knowledge about exhaled breath analysis in MPM diagnosis. A systematic review was conducted on MEDLINE (PubMed), EMBASE and Web of Science databases to identify relevant studies. Quality assessment was done by the Newcastle–Ottawa Scale. Six studies were identified, all of which showed fair quality and explored volatile organic compounds (VOC) based breath profile using Gas Chromatography Coupled to Mass Spectrometry (GC–MS), Ion Mobility Spectrometry Coupled to Multi-capillary Columns (IMS–MCC) or pattern-recognition technologies. Sample sizes varied between 39 and 330. Some compounds (i.e, cyclohexane, P3, P5, P50, P71, diethyl ether, limonene, nonanal, VOC IK 1287) that can be indicative of MPM development in asbestos exposed population were identified with high diagnostic accuracy rates. E-nose studies reported breathprints being able to distinguish MPM from asbestos exposed individuals with high sensitivity and a negative predictive value. Small sample sizes and methodological diversities among studies limit the translation of results into clinical practice. More prospective studies with standardized methodologies should be conducted on larger populations.


Molecules ◽  
2021 ◽  
Vol 26 (12) ◽  
pp. 3776
Author(s):  
Carsten Jaeschke ◽  
Marta Padilla ◽  
Johannes Glöckler ◽  
Inese Polaka ◽  
Martins Leja ◽  
...  

Exhaled breath analysis for early disease detection may provide a convenient method for painless and non-invasive diagnosis. In this work, a novel, compact and easy-to-use breath analyzer platform with a modular sensing chamber and direct breath sampling unit is presented. The developed analyzer system comprises a compact, low volume, temperature-controlled sensing chamber in three modules that can host any type of resistive gas sensor arrays. Furthermore, in this study three modular breath analyzers are explicitly tested for reproducibility in a real-life breath analysis experiment with several calibration transfer (CT) techniques using transfer samples from the experiment. The experiment consists of classifying breath samples from 15 subjects before and after eating a specific meal using three instruments. We investigate the possibility to transfer calibration models across instruments using transfer samples from the experiment under study, since representative samples of human breath at some conditions are difficult to simulate in a laboratory. For example, exhaled breath from subjects suffering from a disease for which the biomarkers are mostly unknown. Results show that many transfer samples of all the classes under study (in our case meal/no meal) are needed, although some CT methods present reasonably good results with only one class.


Data in Brief ◽  
2021 ◽  
Vol 35 ◽  
pp. 106767
Author(s):  
Cristhian Manuel Durán Acevedo ◽  
Carlos A. Cuastumal Vasquez ◽  
Jeniffer Katerine Carrillo Gómez

2016 ◽  
Vol 10 (2) ◽  
pp. 026012 ◽  
Author(s):  
Tali Feinberg ◽  
Layah Alkoby-Meshulam ◽  
Jens Herbig ◽  
John C Cancilla ◽  
Jose S Torrecilla ◽  
...  

2011 ◽  
Vol 5 (3) ◽  
pp. 037110 ◽  
Author(s):  
P Gouma ◽  
A Prasad ◽  
S Stanacevic

ETRI Journal ◽  
2018 ◽  
Vol 40 (6) ◽  
pp. 802-812 ◽  
Author(s):  
Jin-Young Jeon ◽  
Jang-Sik Choi ◽  
Joon-Boo Yu ◽  
Hae-Ryong Lee ◽  
Byoung Kuk Jang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document